Dosage forms that we support:
Oral solid dosage forms and oral liquids
including API or formulated API in a bottle or capsule, immediate release tablets, orally disintegrating tablets, solutions and suspensions
Parenteral dosage forms for infusion and injection
in IV, IM and SC formats
Inhaled and nasal dosage forms
such as dry powder inhalers, solutions and suspensions
Radiolabelled drug products
including powder/API in capsule; oral suspension solution; parenteral; amorphous dispersion (drug product intermediates); and powder/API in bottle for extemporaneous preparation at the clinical unit.
Solubility-enhanced dosage forms
including complexes in a bottle, capsule, or tablet format; lipidic vehicles; micronized API in a bottle, capsule, or tablet format; and amorphous dispersion in a bottle, capsule, or tablet format.